Compare, Analyse Unichem Lab with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   MYLAN
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
MYLAN
Dec-18
UNICHEM LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2923,490-   
Low Rs1821,921-   
Sales per share (Unadj.) Rs167.71,605.9-  
Earnings per share (Unadj.) Rs-3.643.6-  
Cash flow per share (Unadj.) Rs5.9344.3-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.31,737.3-  
Shares outstanding (eoy) m70.38514.50-   
Bonus / Rights / Conversions ESOP--  
Price / Sales ratio x1.41.7 83.9%   
Avg P/E ratio x-65.362.0 -105.2%  
P/CF ratio (eoy) x39.97.9 507.6%  
Price / Book Value ratio x0.61.6 40.9%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6801,391,984 1.2%   
No. of employees `0002.635.0 7.4%   
Total wages/salary Rs m2,3930-   
Avg. sales/employee Rs Th4,535.223,606.9 19.2%   
Avg. wages/employee Rs Th919.80-   
Avg. net profit/employee Rs Th-98.2641.0 -15.3%   
INCOME DATA
Net Sales Rs m11,801826,243 1.4%  
Other income Rs m9840-   
Total revenues Rs m12,785826,243 1.5%   
Gross profit Rs m-835213,801 -0.4%  
Depreciation Rs m674154,705 0.4%   
Interest Rs m7539,739 0.2%   
Profit before tax Rs m-60019,356 -3.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343-3,079 11.2%   
Profit after tax Rs m-25622,436 -1.1%  
Gross profit margin %-7.125.9 -27.3%  
Effective tax rate %57.3-15.9 -360.0%   
Net profit margin %-2.22.7 -79.7%  
BALANCE SHEET DATA
Current assets Rs m20,384461,373 4.4%   
Current liabilities Rs m5,029336,392 1.5%   
Net working cap to sales %130.115.1 860.2%  
Current ratio x4.11.4 295.5%  
Inventory Days Days10584 125.4%  
Debtors Days Days13593 144.5%  
Net fixed assets Rs m9,023160,278 5.6%   
Share capital Rs m141440 32.0%   
"Free" reserves Rs m26,0580-   
Net worth Rs m26,199893,844 2.9%   
Long term debt Rs m0964,745 0.0%   
Total assets Rs m31,4962,397,637 1.3%  
Interest coverage x-7.01.5 -469.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.40.3 108.7%   
Return on assets %-0.62.6 -22.1%  
Return on equity %-1.02.5 -38.9%  
Return on capital %-2.03.2 -62.9%  
Exports to sales %69.40-   
Imports to sales %00-   
Net fx Rs m7,5920-   
CASH FLOW
From Operations Rs m-3,278171,693 -1.9%  
From Investments Rs m-2,860-88,747 3.2%  
From Financial Activity Rs m-24-79,985 0.0%  
Net Cashflow Rs m-4,6901,422 -329.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.32 Rs / USD

Compare UNICHEM LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: ORCHID PHARMA  J.B.CHEMICALS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views On News

Gland Pharma Q4 results: Net profit rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

UNICHEM LAB SHARE PRICE


May 18, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON UNICHEM LAB

UNICHEM LAB - DR. DATSONS LABS COMPARISON

COMPARE UNICHEM LAB WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS